Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Metformin completely reverses fatty liver in mouse model

Sep. 13, 2000

Crohn's disease therapy effective and safe in phase II trial

Sep. 13, 2000

NO donor FK-409 protects against ischemia/reperfusion injury of small intestine

Sep. 13, 2000

FR-167653 exerts beneficial effects in rat model of ischemia/reperfusion liver injury

Sep. 13, 2000

Possible protective role for ECT inhibitor in hepatic I/R injury outlined at recent congress

Sep. 12, 2000

New PLA2 inhibitor protects liver against I/R injury in canine model

Sep. 12, 2000

UR-12746, a novel IBD candidate

Sep. 8, 2000

Licensing opportunity from NIH: cloned genomes of infectious GB virus B

Sep. 8, 2000

Licensing opportunity from NIH: HCV and bovine viral diarrhea virus chimeric genomes

Sep. 6, 2000

Licensing opportunity from NIH: cloned hepatitis C virus genome

Sep. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...